doctorpangloss
Joined 3 years ago
Joined 3 years ago
for example one big lever is student loan debt relief. another is mortgage and auto loans relief. another is reducing the exclusivity period for pharmaceutical patents. so these are taxes in only the metaphorical sense - you get worse medicine with shorter exclusivity periods - but maybe people like that trade?
> the stock market crashing just means cutting back on primarily discretionary spend - think no new car and maybe not buying the family new iPhones every year - they're not in any danger of going hungry, especially if they have any sense.
this is a very paul krugman hand wavey POV. without a doubt, it would be a catastrophe.
Or, you can trade $0.03 of tokens that cost you $0.02 for $1.00 in ANTHROPIC SHARES, which makes the thing that everyone uses for like, math discoveries and curing cancer."
Average Hacker News commenter (not you): "Nooooooo it's not profitable Anthropic is going to crater nobody will take their convertible notes"
Anyway, let's take your theory to its logical conclusion: the product development between real and simulated soft tissue behavior is much bigger than Exponential Time being a hypothesis and being proven. There isn't some effective acceleraltruist path here. Dario Amodei was a biotech dropout. The thing you are betting on which Google is not doing anyway, maybe they will destroy the descriptive single cell sequencing paper mill, but they're not going to be able to simulate the fat inside a BMI 30 abuela undergoing a gallbladder removal.
> "The external collaborations will follow four principles... until Anthropic, Google, DeepSeek, Google and dozens of Chinese companies all make the same offering, in which case we will rediscover and re-implement all of the things you hate about traditional academic advancement and publishing, except because our companies are run by people even more mercurial and self-absorbed than university presidents, we'll wind up supporting even fewer people to do it."
Biotech IPOs are even worse. There are 5-year segments where only about 1 in 40 biotech & pharmaceutical IPOs trade above their IPO price at expiry.
On the flip side, in biotech, biopharma and SaaS, 2025 IPOs had nearly 10x the valuations of 2015 IPOs. So you may trade below expiry, but the structure of the earlier deals you participated in, you make way more money anyway.
if someone knew a better way to improve test scores without cheating on them, we'd use it. it's a very hard problem.
on the flip side it is pretty obvious how construction and manufacturing can be automated and what the impact will be. it's so obvious that we already tariff and ban stuff that, from our POV, is automated, like prefab buildings, for solely political reasons.
people are not questioning whether or not the goal is good or bad. they're showing that the Concern is really a Concern Troll. that is, their concerns aren't really sincere.
that said i think the appropriate meme for this is the Big Chin guy
Step 2. Copy it into your repo. Who cares what the license says, how would the authors of that code ever see it being misused, because the place it is being misused requires a security clearance?
Step 3. Deliver the code as yours.
Truly, how will the people who authored something on GitHub ever know? Any circumstance you describe would require someone without clearance to know implementation details of some software. Which is to say, either the thing I describe happens all the time, or security clearances are overblown.